Clinical trials
Diabetic Foot trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
184 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 5 |
| 2012 | 5 |
| 2013 | 7 |
| 2014 | 6 |
| 2015 | 11 |
| 2016 | 8 |
| 2017 | 11 |
| 2018 | 13 |
| 2019 | 17 |
| 2020 | 8 |
| 2021 | 18 |
| 2022 | 21 |
| 2023 | 25 |
| 2024 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 184 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assiut University | 5 |
| Universidad Complutense de Madrid | 5 |
| Laboratoires URGO | 4 |
| Unity Health Toronto | 4 |
| Hadassah Medical Organization | 3 |
| Hospices Civils de Lyon | 3 |
| Jie Shen | 3 |
| U.S. Wound Registry | 3 |
| University Health Network, Toronto | 3 |
| Affiliated Hospital of Nantong University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetic Foot | 184 |
| Diabetes Mellitus | 32 |
| Varicose Ulcer | 12 |
| Peripheral Vascular Diseases | 10 |
| Foot Ulcer | 8 |
| Chronic Limb-Threatening Ischemia | 7 |
| Pressure Ulcer | 7 |
| Wounds and Injuries | 7 |
| Diabetic Neuropathies | 6 |
| Diabetes Complications | 5 |
Trials
Showing 1 to 25 of 184. Each trial links to its page on Pharma Observatory.
84 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.